Cytek Biosciences, Inc. (CTKB) reported revenue at $57.5 million

Cytek Biosciences, Inc. (NASDAQ: CTKB) reported revenue for the quarter came in at $57.5 million versus the consensus estimate of $61.49 million.

For earnings history and earnings-related data on Cytek Biosciences, Inc. (CTKB) click here.

You May Also Be Interested In

• SolarEdge (SEDG) PT Lowered to $31 at Jefferies, 'We see shares as an unappealing short, not a compelling long'
• Lucky Strike Entertainment (LUCK) PT Lowered to $10 at Texas Capital Securities
• Two Hands Corp launches EntangleX quantum simulation platform